Appeals court rules Medtronic pain pump suit can proceed; FDA pulls proposed employee investigation rule;

 @FierceMedDev: Bayer gains FDA nod for long-use IUD. Story | Follow @FierceMedDev

@MarkHFierce: A Swiss Dx company focused on nanotech brought in $3M in new Series A financing. Article | Follow @MarkHFierce

 @DamianFierce: $LLY's jumping back on the companion diagnostics bandwagon with a new Dako partnership. Report | Follow @DamianFierce

> A federal appeals court ruled that a man who claims he was paralyzed by a Medtronic ($MDT) pain pump can pursue legal action against the company. Story

> Conventus Othopaedics is raising $2 million to help fuel development of a less-invasive implant designed to treat wrist fractures. Story

> UCLA Medical Center in Los Angeles discharged its first patient to receive SynCardia's temporary Total Artificial Heart just before the holidays. His initial heart transplant failed and he is now awaiting a second heart transplant. Item

> Verinata Health believes a blood diagnostic could eliminate the need to perform amniocentesis on women in the first trimester of their pregnancy seeking to detect genetic abnormalities in the fetus. Story

> The FDA has withdrawn a proposed new rule designed to disseminate information relating to investigations into individuals and employees performing work for the FDA. Story

> The U.K.'s London School of Hygiene & Tropical Medicine hosts a new diagnostics center designed to work with other nations to develop diagnostics and biomarkers for diseases in the developing world. Story

Biotech News

 @FierceBiotech: J&J's diabetes drug passes FDA panel test despite safety concerns. Story | Follow @FierceBiotech

@RyanMFierce: Another failure for tivantinib $ARQL. Ph2 in colon cancer after PhIII fiasco in lung cancer last year. | Follow @RyanMFierce

> GSK rests hopes on R&D pipeline after tough 2012. Article

> ArQule, Daiichi cough up another failure for lead cancer drug. Story

Pharma News

@FiercePharma: Stada exec says board would entertain the right offer. Report | Follow @FiercePharma

 @AlisonBFierce: Manufacturers already shipped more than 128M doses of flu vaccine--nearly 95% of the 135M doses made this season. More | Follow @AlisonBFierce

> Merck yanks cholesterol drug Tredaptive from market. News

> Hamburg: FDA has power to require abuse deterrence in painkillers. Item

> Drugmakers run short of Tamiflu, vaccine as flu bug bites hard. Story